NRx Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $32.7M
Liabilities Breakdown FY2021
Total Liabilities: $11.9M
Asset Breakdown
Total Assets: $32.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.6M | 84.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $5.1M | 15.7% |
Liabilities Breakdown
Total Liabilities: $11.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 30.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.2M | 69.1% |